Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.
Journal: Nanomedicine (London, England)
Published: June 02, 2026
CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancer.
Journal: Breast cancer research : BCR
Published: April 11, 2025
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer.
Journal: Oncogene
Published: November 25, 2020
A side-by-side evaluation of [18F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography.
Journal: Oncotarget
Published: June 17, 2019
Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer.
Journal: Breast cancer research : BCR
Published: June 14, 2018
Showing 1-5 of 5
Last Updated: 09/26/2026